PATH Looks Cheap, but 3 Real-World Red Flags Make MRVL the Smarter Buy

PATH looks inexpensive, but price alone is not enough

At roughly $10.11 per share after a 38.7% drop over six months, UiPath looks cheap in the weakest possible way: the stock has weakened faster than the story has improved. It is also near the bottom of its 52-week range and still below its 200-day simple moving average. That combination usually means investors still want more proof before they pay up.

Adoption is real, but the market still wants harder proof

Bulls can point to real usage. Management said it is seeing robust enterprise adoption of its agentic automation platform and highlighted stronger sequential gains in large customer deals. But even after UiPath beat expectations, the stock is still trading through a sharp fade from above $12 to near $10.56 amid bearish sentiment. A lower price can create opportunity, but it does not prove the turnaround is ready.

Reason 1: UiPath growth has slowed enough to cap the AI premium

The core issue is not whether UiPath has a usable product. It does. The issue is that growth has cooled to a pace that may not support a fresh AI re-rating. Full-year revenue rose 13 percent and ARR rose 11 percent. Those are respectable numbers for a more mature software company, but they are modest if investors are supposed to reward the business as an AI leader.

AI product traction is visible, but it has not changed the overall growth curve yet

UiPath does have a meaningful AI footprint. Management says AI product ARR is now nearly $200 million, and 90% of its $1 million-plus ARR customers are using AI products. It also has 357 customers with $1 million-plus ARR. That suggests real adoption inside large enterprises. At the same time, broader ARR growth is still only 11% year over year, which leaves room for skeptics to argue that AI demand is helping, but not yet fast enough to lift the whole business.

Profitability removes disaster risk, but it does not remove valuation pressure

UiPath also is not a broken business. It reached first full-year GAAP profitability and reported FY27 revenue guidance: $1.754–$1.759 billion. The market can appreciate the discipline. Still, a profitable software company growing in the low-teens often attracts a mature-multiple mindset unless growth clearly re-accelerates.

Reason 2: Billings are too soft to signal a clean demand rebound

Billings show what customers are paying for in near real time, rather than what gets recognized over the life of a contract. UiPath reported billings of $433 million in Q3, and year-over-year billings growth averaged 2.3% over the last four quarters. That is a sign worth watching, because it suggests current customer demand is softer than investors likely wanted to see.

That does not mean UiPath lost product value. It does mean new and expansion dollars are landing more slowly than hoped. For stock investors, that matters because weak billings can foreshadow a softer topline later. If billings remain stuck in low single-digit growth, the market has another reason to treat PATH as a mature software name instead of an AI breakout story.

Reason 3: The stock still acts fragile

The chart and sentiment still look vulnerable. UBS lowered its PATH price target from $13 to $12 while keeping a Neutral rating, and trading has recently faded from above $12 to near $10.56. That points to fragile near-term conviction, even if the underlying business is still generating cash.

UiPath is not in immediate distress. It has roughly $632.2M in cash and over $1.3B in cash and short-term investments, low debt, and positive free cash flow. So the main risk is not a balance-sheet break. The risk is owning a stock that can stay cheap longer than expected while the market waits for cleaner operating momentum.

Marvell offers a cleaner way to own AI infrastructure demand

If UiPath still needs better proof of stronger selling, Marvell Technology looks like the cleaner buy. Instead of betting on a software application that still needs to re-accelerate, Marvell gives investors exposure to the hardware layer that supports AI data-center spending.

Marvell already has revenue, profit, and a direct AI infrastructure role

In fiscal 2026, Marvell produced nearly $8.2 billion in revenue, about $2.7 billion in net income, and roughly a 32% net margin. It designs high-speed networking and storage chips for large cloud data centers, and Nvidia and Amazon are key strategic partners. The appeal is straightforward: if AI spending is real, infrastructure suppliers should benefit early and measurably.

The trade-off is customer concentration, not soft current demand

the top ten customers account for roughly 82% of total revenue. That concentration is a real risk. But it is a different risk from UiPath's softer billings growth. Marvell's profile suggests the biggest buyers are still spending heavily. For investors who want AI exposure backed by visible revenue and earnings today, that makes MRVL the easier story to trust right now.